Table 2.
Demographic details of study population.
| Normal | C-IBS | D-IBS | CD | UC | CRC | |
|---|---|---|---|---|---|---|
| Total | 26 (19.5) | 33 (24.8) | 15 (11.3) | 8 (6) | 14 (10.5) | 37 (27.8) |
|
| ||||||
| Age | 53.0 | 48.0 | 49.0 | 43.5 | 43.5 | 66.0 |
|
| ||||||
| Male | 10 (38.5) | 8 (24.2) | 5 (33.3) | 4 (50) | 6 (42.9) | 19 (51.4) |
|
| ||||||
| Female | 16 (61.5) | 25 (75.8) | 10 (66.7) | 4 (50) | 8 (57.1) | 18 (48.6) |
|
| ||||||
| BMI | 25.54 | 26.14 | 28.16 | 21.17 | 25.96 | 28.70 |
|
| ||||||
| Smoke | 6 (23.1) | 7 (21.2) | 5 (33.3) | 5 (62.5) | 1 (7.1) | 5 (13.5) |
|
| ||||||
| NSAIDS | 7 (26.9) | 3 (9.1) | 1 (6.7) | 0 | 0 | 0 |
|
| ||||||
| FH CRC | 1 (3.8) | 3 (9.1) | 1 (6.7) | 0 | 0 | 6 (16.2) |
( ) =%. Percentage expressed for group in all subcategories, except total.
NSAIDS: nonsteroidal anti-inflammatory drugs.
FH CRC: family history of colorectal cancer.